C-CAR011: Ph I CARD-1 started

Cellular began the dose-escalation, Chinese Phase I CARD-1 trial to evaluate 0.8, 2.5 and 5×106 cells/kg C-CAR011 given over 3 infusions in 9 patients. Patients will receive 10% of the selected dose o...